Related Experiment Videos
Structure and function of 17beta-hydroxysteroid dehydrogenase type 1 and type 2
1Biocentre Oulu and WHO Collaborating Centre for Research on Reproductive Health, University of Oulu, P.O. Box 5000, FIN-90014, Oulu, Finland. pvihko@whoccr.oulu.fi
Molecular and Cellular Endocrinology
|February 13, 2001
Summary
17beta-Hydroxysteroid dehydrogenases (17HSDs) are key enzymes in sex steroid metabolism. Inhibiting 17HSD1 offers a promising strategy for treating estrogen-dependent breast cancer by blocking estrogen production.
Area of Science:
- Biochemistry
- Endocrinology
- Molecular Biology
Background:
- 17beta-Hydroxysteroid dehydrogenases (17HSDs) regulate active steroid hormone levels.
- Isoenzymes exhibit distinct tissue distributions and functions in sex steroid metabolism.
- 17HSD1 promotes estradiol synthesis, while 17HSD2 inactivates it.
Purpose of the Study:
- To explore the role of 17HSD isoenzymes in estrogen metabolism and hormone action.
- To understand the structural and mechanistic basis of 17HSD1 activity.
- To evaluate 17HSD1 inhibition as a therapeutic strategy for estrogen-dependent cancers.
Main Methods:
- Biochemical assays to characterize 17HSD enzyme activities.
- Structural determination of human 17HSD1 to elucidate its estradiol binding pocket.
- Analysis of 17HSD isoenzyme expression in normal and malignant breast tissues.
Main Results:
- 17HSD1 activity is crucial for local estradiol production in breast tissue.
- 17HSD2 activity opposes 17HSD1 by converting estradiol to estrone.
- Preliminary data indicate differential expression of 17HSD1 and 17HSD2 in malignant versus non-malignant breast cells.
- The three-dimensional structure of 17HSD1 reveals its mechanism and estrogen specificity.
Conclusions:
- 17HSD isoenzymes play critical roles in modulating sex steroid hormone activity.
- Targeting 17HSD1 presents a viable therapeutic approach for estrogen-dependent breast cancer.
- Understanding 17HSD1 structure-function relationships can guide the development of specific inhibitors.